Boehringer Ingelheim Pharmaceuticals, Inc.
NDC labeler code: 0597
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Dabigatran etexilatePradaxa · 9 products
- Empagliflozin and metformin hydrochlorideSynjardy, Synjardy XR · 8 products
- Linagliptin and metformin hydrochlorideJentadueto, Jentadueto XR · 5 products
- Empagliflozin, linagliptin, metformin hydrochlorideTrijardy XR · 4 products
- AfatinibGilotrif · 3 products
- TiotropiumSpiriva Handihaler, Spiriva Respimat · 3 products
- Telmisartan and hydrochlorothiazideMicardis Hct · 3 products
- SpesolimabSpevigo · 3 products
- NintedanibOfev · 2 products
- EmpagliflozinJardiance · 2 products
- NerandomilastJascayd · 2 products
- Empagliflozin and linagliptinGlyxambi · 2 products
- Tiotropium bromide and olodaterolStiolto Respimat · 1 product
- Ipratropium bromideAtrovent HFA · 1 product
- Olodaterol respimat inhalation sprayStriverdi Respimat · 1 product
- Ipratropium bromide and albuterol sulfateCombivent Respimat · 1 product
- LinagliptinTradjenta · 1 product
- IdarucizumabPraxbind · 1 product
- ZongertinibHernexeos · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| October 7, 2025 | NDA218764 | Nerandomilast JASCAYD | Boehringer Ingelheim |
| August 8, 2025 | NDA219042 | Zongertinib HERNEXEOS | Boehringer Ingelheim |
| September 1, 2022 | BLA761244 | Spesolimab SPEVIGO | Boehringer Ingelheim Pharmaceuticals Inc |
| June 21, 2021 | NDA214358 | Dabigatran etexilate PRADAXA | Boehringer Ingelheim |
| January 27, 2020 | NDA212614 | Empagliflozin, linagliptin, metformin hydrochloride TRIJARDY XR | Boehringer Ingelheim |
| December 9, 2016 | NDA208658 | Empagliflozin and metformin hydrochloride SYNJARDY XR | Boehringer Ingelheim |
| May 27, 2016 | NDA208026 | Linagliptin and metformin hydrochloride JENTADUETO XR | Boehringer Ingelheim |
| October 16, 2015 | BLA761025 | Idarucizumab PRAXBIND | Boehringer Ingelheim |
| September 15, 2015 | NDA207070 | Tiotropium SPIRIVA RESPIMAT | Boehringer Ingelheim |
| August 26, 2015 | NDA206111 | Empagliflozin and metformin hydrochloride SYNJARDY | Boehringer Ingelheim |
| May 21, 2015 | NDA206756 | Tiotropium bromide and olodaterol STIOLTO RESPIMAT | Boehringer Ingelheim |
| January 30, 2015 | NDA206073 | Empagliflozin and linagliptin GLYXAMBI | Boehringer Ingelheim |
| October 15, 2014 | NDA205832 | Nintedanib OFEV | Boehringer Ingelheim |
| September 24, 2014 | NDA021936 | Tiotropium SPIRIVA RESPIMAT | Boehringer Ingelheim |
| August 1, 2014 | NDA204629 | Empagliflozin JARDIANCE | Boehringer Ingelheim |
| July 31, 2014 | NDA203108 | Olodaterol respimat inhalation spray STRIVERDI RESPIMAT | Boehringer Ingelheim |
| July 12, 2013 | NDA201292 | Afatinib GILOTRIF | Boehringer Ingelheim |
| January 30, 2012 | NDA201281 | Linagliptin and metformin hydrochloride JENTADUETO | Boehringer Ingelheim |
| October 7, 2011 | NDA021747 | Ipratropium bromide and albuterol sulfate COMBIVENT RESPIMAT | Boehringer Ingelheim |
| May 2, 2011 | NDA201280 | Linagliptin TRADJENTA | Boehringer Ingelheim |
| October 19, 2010 | NDA022512 | Dabigatran etexilate PRADAXA | Boehringer Ingelheim |
| November 17, 2004 | NDA021527 | Ipratropium bromide ATROVENT HFA | Boehringer Ingelheim |
| January 30, 2004 | NDA021395 | Tiotropium SPIRIVA | Boehringer Ingelheim |
| November 17, 2000 | NDA021162 | Telmisartan and hydrochlorothiazide MICARDIS HCT | Boehringer Ingelheim |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2023
-
March 9, 2023 · Class II · Terminated · D-0468-2023 · Empagliflozin
Labeling: Label Mix-up
JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) bottles, Rx only, Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA an
2022
-
January 26, 2022 · Class II · Terminated · D-0197-2024 · Tiotropium
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) 18 mcg/Capsule, 30 capsules, 3 blister cards, each card contains 10 capsules, Rx only, For oral inhalation only, Distributed by: Boehringer Ingelheim Pharmaceutic
-
January 26, 2022 · Class II · Terminated · D-0185-2024 · Empagliflozin
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37
2021
-
March 15, 2021 · Class II · Terminated · D-0458-2021 · Empagliflozin and metformin hydrochloride
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Synjardy XR (empagliflozin and metformin hydrochloride extended-release) Tablets 25 mg/1000 mg 30 tablets Rx only NDC 0597-0295-88 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA
-
March 15, 2021 · Class II · Terminated · D-0455-2021 · Empagliflozin and linagliptin
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
-
March 15, 2021 · Class II · Terminated · D-0456-2021 · Empagliflozin and metformin hydrochloride
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Synjardy (empagliflozin and metformin hydrochloride) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0168-69 Distributed by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
-
March 15, 2021 · Class II · Terminated · D-0453-2021 · Tiotropium
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Spiriva HandiHaler (tiotropium bromide inhalation powder) For Oral Inhalation Only 18 mcg (as tiotropium) per capsule Rx only NDC 0597-0075-41 Manufactured by: Boehringer Ingelheim (BI) Pharma GmbH & Co. KG Ingelheim, Ge
-
March 15, 2021 · Class II · Terminated · D-0459-2021 · Empagliflozin and metformin hydrochloride
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Synjardy XR (empagliflozin and metformin) hydrochloride extended-release) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0300-45 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
-
March 15, 2021 · Class II · Terminated · D-0457-2021 · Linagliptin and metformin hydrochloride
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets 5 mg/1000 mg 30 tablets Rx only NDC 0597-0275-33 Dist. by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
2018
-
September 4, 2018 · Class II · Terminated · D-1217-2018 · Empagliflozin and metformin hydrochloride
Cross Contamination With Other Products:
Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI
Show the 4 older recalls
2017
-
December 14, 2017 · Class II · Terminated · D-0242-2018 · Tiotropium
Failed Stability Specifications
SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, C
2015
-
July 24, 2015 · Class II · Terminated · D-1279-2015 · Ipratropium bromide and albuterol sulfate
Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.
COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses per inhaler, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefie
2014
-
March 27, 2014 · Class III · Terminated · D-1230-2014 · Tiotropium
Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.
Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With HandiHaler Only, 18 mcg (as tiotropium) per capsule, Rx Only, a) NDC 0597-0075-75, 5 Spiriva capsules per blister c
2013
-
August 30, 2013 · Class III · Terminated · D-1057-2013 · Tiotropium
Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler
SPIRIVA HandiHaler (Tiotropium Bromide Inhalation Powder) Capsules 18 mcg per dose, Rx only, a) 10 count blister (NDC 0597-0075-27), b) 30 count blister (NDC 0597-0075-41), c) 90 count blister (NDC 0597-0075-47), d) 5 co
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026